Phase II study of everolimus and sorafenib for the treatment of metastatic thyroid cancer Meeting Abstract


Authors: Sherman, E. J.; Ho, A. L.; Fury, M. G.; Baxi, S. S.; Haque, S.; Lipson, B. L.; Kurz, S.; Fagin, J. A.; Pfister, D. G.
Abstract Title: Phase II study of everolimus and sorafenib for the treatment of metastatic thyroid cancer
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419602148
PROVIDER: wos
Notes: Meeting Abstract: 6024 -- Source: Wos
MSK Authors
  1. James A Fagin
    107 Fagin
  2. Eric J Sherman
    149 Sherman
  3. Sofia S Haque
    72 Haque
  4. David G Pfister
    246 Pfister
  5. Shrujal S Baxi
    69 Baxi
  6. Matthew G Fury
    93 Fury
  7. Alan Loh Ho
    79 Ho
  8. Brynna Lane Lipson
    8 Lipson
  9. Sarah Tybie Kurz
    3 Kurz